Literature DB >> 8608355

Predictive factors of severity of spondyloarthropathy in North Africa.

P Claudepierre1, A Gueguen, A Ladjouze, N Hajjaj-Hassouni, S Sellami, B Amor, M Dougados.   

Abstract

Both genetic and environmental factors probably influence the severity of Spondyloarthropathies. Hip involvement, which may be used as a marker of disease severity, is more frequent in spondyloarthropathies developed in North Africa. The objective of this study was determine the predisposing factors of hip involvement in spondyloarthropathy in North Africa. Patients fulfilled the Amor or European Spondyloarthropathy Study Group (ESSG) criteria of spondyloarthropathy. The study was retrospective, cross-sectional, multicentre and carried out in North Africa. The data collected were demographic data, socio-cultural factors and clinical presentation at onset. The risk of hip involvement with regard to disease duration was estimated using Kaplan-Meier's method. The predictive value of each variable with regard to time to hip involvement was evaluated using a uni- and then a multivariate Cox proportional hazard model. Five hundred and eighteen patients were included. The risk of hip involvement was estimated at 39+/-3% after 10 yr disease duration. The factors picked up by the multivariate analysis were: diagnostic delay less than 7 yr, age at onset below 24 yr and a combination of 'lower social class' and 'no refrigerator at home'. This study confirms the high prevalence of hip involvement during the course of spondyloarthropathy in North Africa and suggests a role of environmental factors in its appearance.

Entities:  

Mesh:

Year:  1995        PMID: 8608355     DOI: 10.1093/rheumatology/34.12.1139

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  9 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 2.  Spondyloarthritis in North Africa: an update.

Authors:  Samy Slimani; Wafa Hamdi; Kawtar Nassar; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2021-02-09       Impact factor: 2.980

3.  Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.

Authors:  Bahiri Rachid; Bassel El Zorkany; Ehab Youseif; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2012-08-19       Impact factor: 2.980

Review 4.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

5.  Two distinct patterns of ankylosing spondylitis in Moroccan patients.

Authors:  Laila El Mansouri; Rachid Bahiri; Fatima Ezzahra Abourazzak; Radouan Abouqal; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2009-03-04       Impact factor: 2.631

6.  Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis.

Authors:  Kaouther Maatallah; Ines Mahmoud; Safa Belghali; Kawther Ben Abdelghani; Olfa Saidane; Elyes Bouajina; Ahmad Laatar; Rawdha Tekaya; Leila Abdelmoula
Journal:  Caspian J Intern Med       Date:  2018

7.  Ultrasound features of shoulder involvement in patients with ankylosing spondylitis: a case-control study.

Authors:  Sanae Ali Ou Alla; Rachid Bahiri; Hanaa Amine; Hourya El Alaoui; Hanane Rkain; Souad Aktaou; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  BMC Musculoskelet Disord       Date:  2013-09-22       Impact factor: 2.362

Review 8.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

Review 9.  Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.

Authors:  Mohammed Hammoudeh; Sultana Abdulaziz; Hanan Alosaimi; Hanan Al-Rayes; Hussam Aldeen Sarakbi; Matouqa Baamer; Xenofon Baraliakos; Chafia Dahou Makhloufi; Nahid Janoudi; Khalid Shirazy; Joachim Sieper; Uppal Sukhbir
Journal:  J Int Med Res       Date:  2016-01-25       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.